Competitive intelligence on 
 small-molecule drugs and 
 the 90,000 global patents 
 covering them 

Start your free trial now

DrugPatentWatch Ultimate Plan Preview

Profile for Tradename: RYBIX ODT

« Back to Dashboard

Rybix Odt is a drug marketed by Shionogi Inc and is included in one NDA. It is available from one supplier. There is one patent protecting this drug.

The generic ingredient in RYBIX ODT is tramadol hydrochloride. There are thirty-five drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the tramadol hydrochloride profile page.

Summary for Tradename: RYBIX ODT

Patents:1
Applicants:1
NDAs:1
Suppliers: see list1

Pharmacology for Tradename: RYBIX ODT

Drug ClassOpioid Agonist
Mechanism of ActionFull Opioid Agonists

Clinical Trials for: RYBIX ODT

Study to Evaluate Efficacy and Safety in Male Subjects With Premature Ejaculation
Status: Terminated Condition: Premature Ejaculation

Study to Evaluate Efficacy and Safety in Males Subjects With Premature Ejaculation
Status: Terminated Condition: Premature Ejaculation

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Shionogi Inc
RYBIX ODT
tramadol hydrochloride
TABLET, ORALLY DISINTEGRATING;ORAL021693May 5, 2005DISCNNo6,106,861<disabled>Y<disabled>
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013  

For more information try a free trial or see the plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: PatentStatBiotechBlogJournal of Commercial Biotechnology

`abc